Published in Pharma Investments, Ventures and Law Weekly, July 18th, 2004
According to a new Pharmacor study entitled Schizophrenia, generic erosion will exact a heavy toll on the market because these antipsychotics lose patent protection in 2007 or later.
"Generics will have the greatest impact on the U.S. market, which is the largest and most receptive market...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.